EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Adverse Events Associated with Incretin-Based Therapies: A Narrative Review on Mechanisms, Clinical Management, and Risk Mitigation

Mansour Tobaiqy iD, Sulafa Tarek Alqutub iD

Drug Design, Development and Therapy · 2026-07 · Volume 20 · 1-20

DOI: 10.2147/dddt.s622972 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Design, Development and Therapy, 2026-07. Verfasst von Mansour Tobaiqy und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Medical Sciences, College of Medicine, University of Jeddah, Jeddah, Saudi Arabia. Hauptthemen laut MEDLINE: Incretins, Diabetes Mellitus, Type 2, Glucagon-Like Peptide-1 Receptor Agonists, Obesity. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IncretinsDiabetes Mellitus, Type 2Glucagon-Like Peptide-1 Receptor AgonistsObesityHypoglycemic AgentsHumans

Stichwörter der Autor:innen

adverse eventsglucagon-like peptide-1 receptor agonistsmechanistic determinantsobesityrisk mitigationtype 2 diabetes mellitus

Substanzen

IncretinsGlucagon-Like Peptide-1 Receptor AgonistsHypoglycemic Agents

Autor:innen und Institutionen

  • Department of Basic Medical Sciences, College of Medicine, University of Jeddah, Jeddah, Saudi Arabia.
  • Department of Family and Community medicine, College of Medicine, University of Jeddah, Jeddah, Saudi Arabia.

ORCID-Profile: Mansour Tobaiqy, Sulafa Tarek Alqutub

Zitieren

APA

Tobaiqy, M., & Alqutub, S. T. (2026). Adverse Events Associated with Incretin-Based Therapies: A Narrative Review on Mechanisms, Clinical Management, and Risk Mitigation. Drug Design, Development and Therapy, Volume 20, 1-20. https://doi.org/10.2147/dddt.s622972

Vancouver

Tobaiqy M, Alqutub ST. Adverse Events Associated with Incretin-Based Therapies: A Narrative Review on Mechanisms, Clinical Management, and Risk Mitigation. Drug Design, Development and Therapy. 2026;Volume 20:1-20. doi:10.2147/dddt.s622972

BibTeX
@article{Tobaiqy2026,
  author = {Tobaiqy, Mansour and Alqutub, Sulafa Tarek},
  title = {Adverse Events Associated with Incretin-Based Therapies: A Narrative Review on Mechanisms, Clinical Management, and Risk Mitigation},
  journal = {Drug Design, Development and Therapy},
  year = {2026},
  volume = {Volume 20},
  pages = {1--20},
  doi = {10.2147/dddt.s622972}
}
Kostenlos starten →